Back to search
FDAFDA · Food and drugs·Recall number D-007-2013

Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 ,

Published October 17, 2012 · Recall initiated: October 3, 2012

Summary

FDA records drug Class II recall D-007-2013, published October 17, 2012 and initiated October 3, 2012. Recalling firm: Paddock Laboratories, LLC; Status: Terminated; Reported quantity: 2267 bottles; Lot: 2012028142 exp. 1/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Paddock Laboratories, LLC
Distributor
Nationwide
Lot
2012028142 exp. 1/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Moexipril HCl Tablets 7.5mg, 100 tabs, Rx Only, Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0110-01 , recalled?

Yes. FDA published recall D-007-2013 on October 17, 2012. Reported hazard: Paddock Laboratories, LLC are recalling one lot (2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.

What should I do if I have this product?

Voluntary: Firm initiated · Letter